Abstract：
:Heart failure with preserved ejection fraction (HFPEF) is a common subtype of heart failure with morbidity and mortality similar to that of heart failure with systolic dysfunction. This article discusses the numerous biomarkers that promise to play a substantial role in terms of our ability to understand the mechanisms of HFPEF and discern possible phenotypes that respond to targeted therapies: natriuretic peptides, high-sensitivity troponins, galectin-3, soluble ST2, neutrophil gelatinase-associated lipocalin, and cystatin C.
journal_name
Heart Fail Clinjournal_title
Heart failure clinicsauthors
Shah KS,Maisel ASdoi
10.1016/j.hfc.2014.04.005subject
Has Abstractpub_date
2014-07-01 00:00:00pages
471-9issue
3eissn
1551-7136pii
S1551-7136(14)00029-4journal_volume
10pub_type
杂志文章,评审